Take a beat before investing in the latest analytical tools. Capability and sensitivity come at a cost. Depending on your phase, you might not need it just yet.
- Why Delivery Is Defining The Next Era Of Neuromuscular Therapeutics
- What Goes Into Restarting A Shelved Orphan Drug Candidate?
- A Much-Improved Approach For Understanding And Managing Safety Risks
- Immune Reset In Rheumatology: Moving Beyond Disease Suppression Toward Durable Remission
- CSV Assumes The AI System Sits Still — It Doesn't.
- Building Antigen-Specific Immune Tolerance For Autoimmune Disease
- July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
- Combination Cell Therapy's Clinical Success Hinges On Manufacturability
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![450_300-high_oxygen_demanding_microorganisms]( "Aerobic Cultivation Of High-Oxygen-Demand Microorganisms")
Aerobic Cultivation Of High-Oxygen-Demand MicroorganismsDiscover how oxygen-enriched conditions and smart feeding strategies boost microbial growth. Prevent oxygen limitation, improve productivity, and maintain control for high-density bioprocessing success.
-
![GettyImages-1066989062-gene-cell-doctor-research]( "Vial Adapter Transfer Device Compatibility With Cell Therapies")
Vial Adapter Transfer Device Compatibility With Cell TherapiesNeedles and syringes are commonly used to retrieve cell therapies from vials, posing the risk of needle stick injury. Explore the suitability of needle-free polycarbonate transfer devices.
-
![GettyImages-1336251027 IT Specialist Using Laptop Computer In Data Center]( "How We Used Intelligent Automation to Transform Vendor Selection")
How We Used Intelligent Automation to Transform Vendor SelectionDiscover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.
-
![GettyImages-2183234647 AAV]( "Scale-Up Of AAV Production In Fixed-Bed Bioreactors")
Scale-Up Of AAV Production In Fixed-Bed BioreactorsConsistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.
-
![GettyImages-1076055404 chromatography, purification]( "Mild pH Protein A Purification Step With A Mild Elution Resin")
Mild pH Protein A Purification Step With A Mild Elution ResinAs antibody formats diversify, low-pH protein A elution can drive aggregation and yield loss. Learn how milder elution conditions during capture can help protect sensitive molecules and ease challenges.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "A Comprehensive Solution For Adventitious Agent Testing")
A Comprehensive Solution For Adventitious Agent TestingModern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.
-
![clinical-trials-regulation-GettyImages-2211671788]( "9 Logistics And Distribution Recommendations For CGTs")
9 Logistics And Distribution Recommendations For CGTsCell and gene therapy commercialization requires tailored logistics strategies. Explore nine recommendations covering site readiness, reimbursement gaps, packaging, testing, and coordination.
-
![GettyImages-2152658176 oncology, doctor, patient]( "5 Operational Gaps To Avoid CGT Patient Risks")
5 Operational Gaps To Avoid CGT Patient RisksExamine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.
-
![GettyImages-2165447062-DNA-strand-ai-futuristic]( "Automation Of iPSC Culture, Passaging, And Expansion")
Automation Of iPSC Culture, Passaging, And ExpansionFind out how iPSC-derived models enable researchers to generate diverse cell types and tissues as well as how automation reduces the labor-intensive culturing process with AI-powered decision-making.
-
![GettyImages-1426571837-vial-laboratory-pipette-equipment]( "Selecting A Platform Filter For High Concentration mAbs")
Selecting A Platform Filter For High Concentration mAbsRead more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
NEWSLETTER ARCHIVE
- 08.24.26 -- The Decision Rights Matrix: Making Sponsor-CDMO Governance Enforceable
- 08.21.26 -- Smarter Workflows For Cell & Gene Production
- 08.21.26 -- Rewriting The Playbook For Stargardt Disease With Shannon Boye, Ph.D.
- 08.20.26 -- Are Biopharma Companies Outsourcing Their Ability To Think?
- 08.19.26 -- Building A More Scalable Gene Therapy Program
- Reimagining Solid Tumor Immunotherapy With SRC-3-Edited Tregs
- Building Antigen-Specific Immune Tolerance For Autoimmune Disease
- Solving Vector Yield Challenges Starts Long Before Manufacturing
- Full FDA Approval For TECELRA Marks More Than A Regulatory Win For Solid Tumors
- FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
